Cargando…

基于HRCT亚厘米肺磨玻璃结节良恶性预测模型建立与验证

Background and objective Pre-operative accuracy of subcentimeter ground glass nodules (SGGNs) is a difficult problem in clinical practice, but there are few clinical studies on the benign and malignant prediction model of SGGNs. The aim of this study was to help identify benign and malignant lesions...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhengwei, CHEN, Gaoxiang, WANG, Hanran, WU, Mingsheng, WU, Xianning, WU, Meiqing, XU, Mingran, XIE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial board of Chinese Journal of Lung Cancer 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273148/
https://www.ncbi.nlm.nih.gov/pubmed/37316447
http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.15
_version_ 1785059639001350144
author Zhengwei, CHEN
Gaoxiang, WANG
Hanran, WU
Mingsheng, WU
Xianning, WU
Meiqing, XU
Mingran, XIE
author_facet Zhengwei, CHEN
Gaoxiang, WANG
Hanran, WU
Mingsheng, WU
Xianning, WU
Meiqing, XU
Mingran, XIE
author_sort Zhengwei, CHEN
collection PubMed
description Background and objective Pre-operative accuracy of subcentimeter ground glass nodules (SGGNs) is a difficult problem in clinical practice, but there are few clinical studies on the benign and malignant prediction model of SGGNs. The aim of this study was to help identify benign and malignant lesions of SGGNs based on the imaging features of high resolution computed tomography (HRCT) and the general clinical data of patients, and to build a risk prediction model. Methods This study retrospectively analyzed the clinical data of 483 patients with SGGNs who underwent surgical resection and were confirmed by histology from the First Affiliated Hospital of University of Science and Technology of China from August 2020 to December 2021. The patients were divided into the training set (n=338) and the validation set (n=145) according to 7:3 random assignment. According to the postoperative histology, they were divided into adenocarcinoma group and benign lesion group. The independent risk factors and models were analyzed by univariate analysis and multivariate Logistic regression. The receiver operator characteristic (ROC) curve was constructed to evaluate the model differentiation, and the calibration curve was used to evaluate the model consistency. The clinical application value of the decision curve analysis (DCA) evaluation model was drawn, and the validation set data was substituted for external verification. Results Multivariate Logistic analysis screened out patients' age, vascular sign, lobular sign, nodule volume and mean-CT value as independent risk factors for SGGNs. Based on the results of multivariate analysis, Nomogram prediction model was constructed, and the area under ROC curve was 0.836 (95%CI: 0.794-0.879). The critical value corresponding to the maximum approximate entry index was 0.483. The sensitivity was 76.6%, and the specificity was 80.1%. The positive predictive value was 86.5%, and the negative predictive value was 68.7%. The benign and malignant risk of SGGNs predicted by the calibration curve was highly consistent with the actual occurrence risk after sampling 1,000 times using Bootstrap method. DCA showed that patients showed a positive net benefit when the predictive probability of the predicted model probability was 0.2 to 0.9. Conclusion Based on preoperative medical history and preoperative HRCT examination indicators, the benign and malignant risk prediction model of SGGNs was established to have good predictive efficacy and clinical application value. The visualization of Nomogram can help to screen out high-risk groups of SGGNs, providing support for clinical decision-making.
format Online
Article
Text
id pubmed-10273148
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Editorial board of Chinese Journal of Lung Cancer
record_format MEDLINE/PubMed
spelling pubmed-102731482023-06-17 基于HRCT亚厘米肺磨玻璃结节良恶性预测模型建立与验证 Zhengwei, CHEN Gaoxiang, WANG Hanran, WU Mingsheng, WU Xianning, WU Meiqing, XU Mingran, XIE Zhongguo Fei Ai Za Zhi Clinical Research Background and objective Pre-operative accuracy of subcentimeter ground glass nodules (SGGNs) is a difficult problem in clinical practice, but there are few clinical studies on the benign and malignant prediction model of SGGNs. The aim of this study was to help identify benign and malignant lesions of SGGNs based on the imaging features of high resolution computed tomography (HRCT) and the general clinical data of patients, and to build a risk prediction model. Methods This study retrospectively analyzed the clinical data of 483 patients with SGGNs who underwent surgical resection and were confirmed by histology from the First Affiliated Hospital of University of Science and Technology of China from August 2020 to December 2021. The patients were divided into the training set (n=338) and the validation set (n=145) according to 7:3 random assignment. According to the postoperative histology, they were divided into adenocarcinoma group and benign lesion group. The independent risk factors and models were analyzed by univariate analysis and multivariate Logistic regression. The receiver operator characteristic (ROC) curve was constructed to evaluate the model differentiation, and the calibration curve was used to evaluate the model consistency. The clinical application value of the decision curve analysis (DCA) evaluation model was drawn, and the validation set data was substituted for external verification. Results Multivariate Logistic analysis screened out patients' age, vascular sign, lobular sign, nodule volume and mean-CT value as independent risk factors for SGGNs. Based on the results of multivariate analysis, Nomogram prediction model was constructed, and the area under ROC curve was 0.836 (95%CI: 0.794-0.879). The critical value corresponding to the maximum approximate entry index was 0.483. The sensitivity was 76.6%, and the specificity was 80.1%. The positive predictive value was 86.5%, and the negative predictive value was 68.7%. The benign and malignant risk of SGGNs predicted by the calibration curve was highly consistent with the actual occurrence risk after sampling 1,000 times using Bootstrap method. DCA showed that patients showed a positive net benefit when the predictive probability of the predicted model probability was 0.2 to 0.9. Conclusion Based on preoperative medical history and preoperative HRCT examination indicators, the benign and malignant risk prediction model of SGGNs was established to have good predictive efficacy and clinical application value. The visualization of Nomogram can help to screen out high-risk groups of SGGNs, providing support for clinical decision-making. Editorial board of Chinese Journal of Lung Cancer 2023-05-20 /pmc/articles/PMC10273148/ /pubmed/37316447 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.15 Text en Copyright © 2023《中国肺癌杂志》编辑部 https://creativecommons.org/licenses/by/3.0/This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/.
spellingShingle Clinical Research
Zhengwei, CHEN
Gaoxiang, WANG
Hanran, WU
Mingsheng, WU
Xianning, WU
Meiqing, XU
Mingran, XIE
基于HRCT亚厘米肺磨玻璃结节良恶性预测模型建立与验证
title 基于HRCT亚厘米肺磨玻璃结节良恶性预测模型建立与验证
title_full 基于HRCT亚厘米肺磨玻璃结节良恶性预测模型建立与验证
title_fullStr 基于HRCT亚厘米肺磨玻璃结节良恶性预测模型建立与验证
title_full_unstemmed 基于HRCT亚厘米肺磨玻璃结节良恶性预测模型建立与验证
title_short 基于HRCT亚厘米肺磨玻璃结节良恶性预测模型建立与验证
title_sort 基于hrct亚厘米肺磨玻璃结节良恶性预测模型建立与验证
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273148/
https://www.ncbi.nlm.nih.gov/pubmed/37316447
http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.15
work_keys_str_mv AT zhengweichen jīyúhrctyàlímǐfèimóbōlíjiéjiéliángèxìngyùcèmóxíngjiànlìyǔyànzhèng
AT gaoxiangwang jīyúhrctyàlímǐfèimóbōlíjiéjiéliángèxìngyùcèmóxíngjiànlìyǔyànzhèng
AT hanranwu jīyúhrctyàlímǐfèimóbōlíjiéjiéliángèxìngyùcèmóxíngjiànlìyǔyànzhèng
AT mingshengwu jīyúhrctyàlímǐfèimóbōlíjiéjiéliángèxìngyùcèmóxíngjiànlìyǔyànzhèng
AT xianningwu jīyúhrctyàlímǐfèimóbōlíjiéjiéliángèxìngyùcèmóxíngjiànlìyǔyànzhèng
AT meiqingxu jīyúhrctyàlímǐfèimóbōlíjiéjiéliángèxìngyùcèmóxíngjiànlìyǔyànzhèng
AT mingranxie jīyúhrctyàlímǐfèimóbōlíjiéjiéliángèxìngyùcèmóxíngjiànlìyǔyànzhèng